Table 1 Participant characteristics
Variables | Patients (n = 59) |
|---|---|
Age ± SD (years) | 72.2 ± 12 |
Females | 39 (66) |
Underlying disease | 38/59 (64.4) |
Hypertension | 25 (65.8) |
Diabetes mellitus | 13 (34.2) |
Asthma | 7 (18.4) |
Heart disease | 14 (36.8) |
Renal disease | 4 (10.5) |
Smoker | 3 (7.9) |
Drinker | 4 (10.5) |
Altered D-dimer (> 500 ng/mL) | 18/49 (36.7) |
Altered NT-proBNP (> 300 pg/mL) | 9/58 (15.5) |
Influenza-Vaccinated_19/20 | 33 (55.9) |
CMV-Seropositive | 49 (83) |
Symptomatic of COVID-19 disease | 36/56 (61) |
Fever | 24 (66.7) |
Cough | 24 (66.7) |
Dyspnoea | 9 (25) |
Chest pain | 5 (13.9) |
Ageusia | 9 (25) |
Anosmia | 11 (30.6) |
Mean days with symptoms ± SD | 3.3 ± 2.7 |